secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoHealth, Inc. (GOCO)
CIK:        0001808220
Form:       8-K
Filed at:   2022-09-15T23:59:59+00:00
Accession:  0001193125-22-245663
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GoHealth director Tawil resigns; Christopher Litchford appointed as Centerbridge designee
--------------------------------------------------------------------------------

- Tawil resigned as Centerbridge director on Sept 11, 2022; no disagreement with GoHealth.
- Christopher Litchford, Managing Director at Centerbridge, appointed to Board on Sept 14, 2022.
- Litchford will serve as Class II director with term expiring at the 2025 annual meeting.
- Litchford receives no additional compensation for board service; standard indemnification executed.
- No reportable related-party transactions between Litchford and GoHealth beyond Centerbridge matters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808220/000119312522245663/0001193125-22-245663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808220/000119312522245663/d256310d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-245663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer